MUSE

Serial Number 97051729
654

Registration Progress

Application Filed
Sep 29, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
97051729
Filing Date
September 29, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
654
Status Date
Jan 27, 2025
Application
Pending
Classes
044

Rights Holder

Medalogix LLC

16
Address
401 Commerce St., Suite 360
Nashville, TN 37219

Ownership History

Medalogix LLC

Original Applicant
16
Nashville, TN

Legal Representation

Attorney
Edward D. Lanquist, Jr.

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description
Apr 1, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 27, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 27, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 27, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 27, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 20, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 10, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 1, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 2, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 2, 2022 GNSL S LETTER OF SUSPENSION E-MAILED
Dec 2, 2022 CNSL R SUSPENSION LETTER WRITTEN
Nov 2, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 24, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 4, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 4, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 4, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 23, 2022 GNRT F NON-FINAL ACTION E-MAILED
Jun 23, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2022 CNRT R NON-FINAL ACTION WRITTEN
Jun 23, 2022 DOCK D ASSIGNED TO EXAMINER
Oct 27, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Consultation services in the fields of health care, medical, pharmaceutical and population health data, namely, data analytics, namely, data and medical analysis for the treatment of persons at end-of-life, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life; providing health care information; providing health related analytics, namely, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life; providing web-based access to health related analytics, namely, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life
First Use Anywhere: Jan 13, 2020
First Use in Commerce: Jan 13, 2020

Classification

International Classes
044